ARVN outlines clinical pipeline readouts across four programs
ARVN said key data readouts are expected for four programs over the next 15 months. It highlighted ARV-393 and ARV-102 nearing pivotal milestones, plus biomarker-driven progress for SBMA and HPK1.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.